Silica ch-OSA 10mg, 12-Week Skin Thickness +30% Connective Tissue Crosslinking
WELLNESS

Silica ch-OSA 10mg, 12-Week Skin Thickness +30% Connective Tissue Crosslinking

By Léa · · Archives of Dermatological Research
KO | EN

A 12-week RCT of choline-stabilized orthosilicic acid (ch-OSA) 10 mg elemental silicon/day improving skin thickness and connective tissue markers simultaneously in women aged 40~65 has been published. The molecular basis of silica — “the forgotten mineral of connective tissue” — has been re-validated.

Clinical Data

A double-blind RCT in 120 women aged 40~65 randomized 1:1 to ch-OSA 10 mg (elemental silicon)/day or placebo. After 12 weeks, the primary endpoint was skin ultrasound (20 MHz) thickness; secondary endpoints were Cutometer elasticity + nail strength (nano-indentation) + hair tensile strength.

The ch-OSA arm showed:

  • Skin thickness +30% (p<0.001)
  • Skin elasticity R2 +18%
  • Nail strength +24%
  • Nail brittleness -42%
  • Hair tensile strength +14%
  • Fine wrinkles -12%

Simultaneous improvement across skin + nail + hair three axes differentiates from other molecular matrices.

Mechanism: Connective Tissue Crosslinking

Silicon is a trace element present at 7 g in the human body. Not classified scientifically as “essential” but clinically core to connective tissue:

Collagen crosslinking:

  • Silica acts as a crosslink molecule between collagen fibers
  • Determines connective tissue tensile strength

Elastin synthesis:

  • Supports elastin protein synthesis
  • The molecular basis of skin elasticity

Glycosaminoglycan (GAG) synthesis:

  • Hyaluronic acid, chondroitin sulfate, etc.
  • Skin hydration + joint cartilage + connective tissue volume

Prolyl hydroxylase activity:

  • Cofactor action with vitamin C
  • Collagen synthesis enzyme activity

These four axes combine to form the molecular basis of all connective tissue.

ch-OSA vs Other Silica Forms

Form-by-form silica differences are decisive:

ch-OSA (choline-stabilized orthosilicic acid) - clinical standard

  • +60% absorption (vs other forms)
  • Extensive clinical data
  • Commercialized as BioSil

Silicon dioxide (SiO₂) - most common

  • Very low absorption (<5%)
  • Minimal clinical effect
  • Used as food additive

Horsetail extract (Equisetum) - traditional

  • Plant extract containing silica
  • Variable absorption
  • Some clinical data

Sodium silicate - some supplements

  • Moderate absorption
  • Limited clinical data

Forms other than ch-OSA show inconsistent clinical effects due to absorption issues. BioSil is the source of 90% of clinical data.

Whole Food Content

Silica-rich whole foods:

  • Bamboo shoots (dried): ~70 mg/100 g
  • Whole grain oats: ~40 mg/100 g
  • Barley: ~35 mg/100 g
  • Beer (traditional): ~6 mg/glass
  • Spring water: ~5~15 mg/L (regional variation)

Daily 5~15 mg intake possible from whole foods alone. Clinical efficacy (10 mg ch-OSA) is more consistent with supplements.

Clinical Indications

Silica is a multi-axis molecule of the connective tissue matrix:

  • Skin thickness: 12-week +30% (largest among molecules)
  • Skin elasticity: +18%
  • Nail strength: +24%, brittleness -42%
  • Hair tensile: +14%
  • Joint health: synergy with glucosamine and chondroitin
  • Bone health: synergy with vitamin D and calcium (BMD support)

Clinical Application

  • Standard dose: ch-OSA 5~10 mg elemental silicon/day
  • Standardization markers: BioSil (Bio Minerals NV) or ch-OSA labeling
  • Absorption: independent of food, fasted intake possible
  • Timing: 1~2 split doses or single
  • Whole food adjunct: whole grains, bamboo shoots, spring water
  • Onset: week 8, stable at week 12. Faster effects on nails and hair
  • Side effects: very rare GI discomfort; extensive safety data
  • Caution: caution in renal failure (eGFR <30); limited data during pregnancy/lactation
  • Synergistic matrix: collagen peptide + vitamin C + Centella + astaxanthin

Position in the Matrix

Silica is the “crosslink + volume” molecule of the collagen and connective tissue matrix. Collagen peptide for raw materials, vitamin C for enzyme, silica for crosslinks + GAG synthesis, Centella for signaling, astaxanthin for protection — five axes target different stages. Clinical data shows single-molecule +14~30% vs matrix +35~50% amplification. Silica’s special position in the matrix is the simultaneous skin + nail + hair three-axis effect.